Shubhangi Peche
Neurology with Special Qualifications in Child Neurology · Springfield, ILNPI 1063681336
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by UCB, Inc. at 40.4% of the total. 2025 is the largest year on record at $1,140, more than ten times the $76 reported in 2019.
Across 199 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- Neurelis, Inc.$401
- Jazz Pharmaceuticals Inc.$333
- Livanova USA, Inc.$314
- Acadia Pharmaceuticals Inc$137
- AstraZeneca$134
- plus $838 from 19 others
What the payments were for
- Food & beverage$3,612100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 94 | $1,464 |
| Neurelis, Inc. | 16 | $401 |
| Jazz Pharmaceuticals Inc. | 14 | $333 |
| Livanova USA, Inc. | 15 | $314 |
| Acadia Pharmaceuticals Inc | 7 | $137 |
| AstraZeneca(2 entities) | 5 | $134 |
| Greenwich Biosciences, Inc. | 5 | $132 |
| PTC Therapeutics, Inc. | 2 | $104 |
| Eisai Inc. | 4 | $78 |
| Immedica Pharma US, Inc. | 3 | $63 |
| Sunovion Pharmaceuticals Inc. | 9 | $62 |
| Supernus Pharmaceuticals, Inc. | 4 | $60 |
| Biogen | 2 | $46 |
| Zogenix Inc. | 2 | $43 |
| Springworks Therapeutics, Inc. | 2 | $38 |
| Amneal Pharmaceuticals LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Aprecia Pharmaceuticals, LLC | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| AbbVie | 1 | $17 |
| Cranial Technologies, Inc | 1 | $16 |
| Sarepta Therapeutics, Inc. | 1 | $16 |
| Aquestive Therapeutics, Inc. | 1 | $15 |
| Travere Therapeutics, Inc. | 4 | $9 |
How this compares
$3,621 in reported general payments places this provider in the 70th percentile of 57 neurology with special qualifications in child neurology providers in Illinois.
See all neurology with special qualifications in child neurology providers in Illinois →
Other neurology with special qualifications in child neurology in Springfield
- Hossam AbdelsalamSpringfield$3K
- Sonam VermaSpringfield$2K
- Douglas NordliChicago$621K
- Nancy KuntzChicago$503K
- Ryan CoatesOak Lawn$163K
- Vamshi RaoChicago$124K
- Takijah HeardEvanston$94K
- John MillichapChicago$84K
- Sookyong KohChicago$60K
- M KaterjiNaperville$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.